Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 232
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06354127 | DWP450 for Treating Moderate to Severe Glabellar Lines | ||
| NCT04749173 | To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers. | ||
| NCT01094834 | A Multiple Dose Study of DWP05195 in Healthy Adult Subjects | ||
| NCT00969787 | DWP05195 in Healthy Adult Male Volunteers | ||
| NCT01634321 | The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty | ||
| NCT04613895 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
| NCT06119945 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers | ||
| NCT04161001 | Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 | ||
| NCT06027307 | Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation | ||
| NCT01945684 | A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity | ||
| NCT06751121 | Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori | ||
| NCT06399835 | Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis | ||
| NCT04592835 | To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003 | ||
| NCT03517319 | Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity | ||
| NCT03184402 | Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2) | ||
| NCT02622685 | A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects | ||
| NCT05184179 | Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab | ||
| NCT05816681 | Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea. | ||
| NCT07190391 | Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis | ||
| NCT05378360 | DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities | ||
| NCT07267221 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition. | ||
| NCT06682000 | Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension | ||
| NCT02089399 | Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers | ||
| NCT06272630 | Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease | ||
| NCT04827472 | Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers | ||
| NCT02346045 | Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension | ||
| NCT04767815 | To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers | ||
| NCT02947815 | Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm | ||
| NCT05500898 | Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults | ||
| NCT05954247 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers | ||
| NCT07730138 | Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer | ||
| NCT05660122 | A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab | ||
| NCT04520022 | Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB | ||
| NCT01493856 | A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276 | ||
| NCT01629875 | Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line | ||
| NCT04278391 | Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers | ||
| NCT05109702 | A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye | ||
| NCT05414591 | Pharmacokinetics and Safety Following Administration of DWP16001 | ||
| NCT05207176 | Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities | ||
| NCT02069717 | Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) | ||
| NCT02502721 | A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152 | ||
| NCT04634500 | The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. | ||
| NCT04014023 | Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT03947489 | Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions | ||
| NCT01099891 | The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients | ||
| NCT06419816 | Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus | ||
| NCT04524052 | To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19 | ||
| NCT01397240 | The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients | ||
| NCT06736587 | Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers |
